slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 20,701-20,730
Pages 1,437
Rows per page 30
Arc
20,701-20,730 of 43,093
13
Includes a biological pathway diagram illustrating the mechanism of action of PHAD on TLR4 pathways.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Includes a small sketch of the test device with a 3-inch scale reference.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · Financials1 hit
17
Includes footnotes detailing warrant and option exercise prices.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · Financials1 hit
18
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · The Ask1 hit
03
Includes non-GAAP financial measure disclosures.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
04
The slide uses a stacked bar chart for total balances and a horizontal bar chart for growth composition.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
05
The slide highlights a strategic shift in lending composition, specifically noting a reduction in capital call lending.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
06
The Q3 2022 column is highlighted with a box.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
07
Includes a footnote regarding non-GAAP financial measures.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
08
The slide uses a combination of bar charts for balances and line charts for yields to illustrate the components of net interest margin.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
09
The slide presents a comprehensive financial snapshot of the securities portfolio as of Q3 2022.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
10
The chart uses a dual-bar structure for each shock scenario to compare two time periods.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial HighlightsLoop · Cost Of Inaction1 hit
11
The slide uses a combination of a bar chart for trend analysis and a data table for granular performance attribution.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
12
The chart combines a bar chart for expenses and a line chart for efficiency ratio.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
13
Includes a comparison of capital ratios against regulatory limits and a trend analysis of book value per share.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
14
Includes a footnote regarding non-GAAP financial measures.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Financial Highlights1 hit
18
Includes a historical bar chart of total assets from 2001 to 2022Q3.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Product and Services1 hit
19
Signature Bank | Results Presentation Deck | 30 slidesSignature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Product and Services1 hit
20
The slide uses a hub-and-spoke diagram for competitors and a pyramid/funnel diagram for Signature Bank to illustrate service delivery models.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Product and Services1 hit
23
The chart tracks three distinct metrics over time. A note at the bottom explains a 2019 dip in banking teams due to organizational restructuring.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Product and Services1 hit
03
The slide uses a molecular structure graphic to reinforce the pharmaceutical theme.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Problem1 hit
04
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Problem1 hit
05
The slide maps specific university/corporate partners to their respective drug development programs (SP-26, SPU-16, SPU-21, SPC-14, SPC-15, Generic psilocybin).Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Problem1 hit
09
The slide outlines the market opportunity, technology, and specific applications for the SP-26 program.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
10
Slide 10 of a pitch deck for Silo Pharma.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
11
The slide outlines a specific asset (SPU-21) under a license agreement with UMB, detailing market size, technical mechanism, and research status.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
12
Slide 12 of a pitch deck.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
13
The slide outlines a specific pharmaceutical asset (SPC-15) and its market context.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit